XML 128 R112.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Instruments - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Other long-term assets $ 15,400,000 $ 11,200,000  
Cumulative impairments 10,000,000 9,000,000  
Impairment loss 1,000,000 4,000,000 $ 5,000,000
Interest expense 91,800,000 99,600,000 92,000,000.0
Tax (expense) benefit related to derivative instruments and hedging activities recognized in other comprehensive income (loss) 7,500,000 (800,000) (5,500,000)
Derivative contracts transfers in to Level 3 fair value hierarchy 0 0  
Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Derivative contracts classified within Level 3 of fair value hierarchy 0 0  
Estimate of Fair Value Measurement | Level 3 | Xevo Inc.      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Intangible assets     90,100,000
Designated as Hedging Instrument | Foreign currency contracts, net | Derivative Instruments and Hedging      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Pretax net gains (losses) related to derivative instruments and hedging activities in accumulated other comprehensive loss (16,100,000) 4,700,000  
Net investment hedges | Designated as Hedging Instrument | Interest Rate Swap      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Interest expense $ 6,500,000 $ 6,500,000 $ 1,800,000